NDC 50090-6706 – Hadlima
Adalimumab 40 mg/.8mL · Solution · Subcutaneous
Product NDC50090-6706
Product details
- Brand name
- Hadlima
- Generic name
- Adalimumab-bwwd
- Labeler
- A-S Medication Solutions
- Dosage form
- Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761059
- Marketed since
- July 1, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Tumor Necrosis Factor Blocker
Active ingredients
- Adalimumab 40 mg/.8mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50090-6706-0 | 2 CARTON in 1 CARTON (50090-6706-0) / 1 mL in 1 CARTON | Sep 27, 2023 |
Other Hadlima products
- 50090-6705 Adalimumab 40 mg/.8mL · Solution · A-S Medication Solutions
- 50090-6707 Adalimumab 40 mg/.4mL · Solution · A-S Medication Solutions
- 78206-183 Adalimumab 40 mg/.8mL · Solution · Organon LLC
- 78206-184 Adalimumab 40 mg/.8mL · Solution · Organon LLC
- 78206-185 Adalimumab 40 mg/.8mL · Solution · Organon LLC
- 78206-186 Adalimumab 40 mg/.4mL · Solution · Organon LLC
- 78206-187 Adalimumab 40 mg/.4mL · Solution · Organon LLC